OrsoBio
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Palo Alto, California, United StatesWebsite
www.orsobio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About OrsoBio
OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders. Our dedicated, highly skilled, and cohesive team of physicians and scientists bring decades of clinical and drug development experience, from academia and industry, that serves as the foundation of our company.Explore more
OrsoBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OrsoBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if OrsoBio has recently received funding, and reach out quickly before it becomes old news!
OrsoBio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once OrsoBio has new funding data
Click to see if OrsoBio had a recent Job posting/layoffs
Check out if OrsoBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when OrsoBio launches new products
Congratulate Masked Content for being promoted to Masked Content at OrsoBio
Earning: See what the market has to say on OrsoBio recently announced quarterly report
Recommended Actions
Find VP level buyers at OrsoBio
Find 3 more new buyers
Compare Similar Companies to OrsoBio
Compare insights from companies similar to OrsoBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OrsoBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OrsoBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OrsoBio.
OrsoBio financials insights
Gather financial insights about OrsoBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$60M
2024
Series B
$67M
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Project
Laboratory Operations, Medical Research, Operations
Funding
OrsoBio News & Media
OrsoBio Inks Oversubscribed $67 Million Series B
MENLO PARK, CA, OrsoBio, a clinical-stage biopharmaceutical company, announced the close of an oversubscribed $67 million Series B financing.Obesity drug startup raises $67M; Vor's 'shielded transplant' shows promise
OrsoBio is advancing several weight loss medicines. Elsewhere, Boehringer Ingelheim pushed forward with a geographic atrophy drug and Vaxcyte raised $1.3 billion.OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders
MENLO PARK, Calif.--(BUSINESS WIRE)-- #OrsoBio--OrsoBio announces oversubscribed $67 Million series B financing. Company plans to accelerate development of mitochondrial protonophore portfolio.OrsoBio to Present Phase 1 and Preclinical Data for Liver-Targeted Mitochondrial Protonophore TLC-6740 at the American Diabetes Association’s 84th Scientific Sessions
MENLO PARK, Calif.--(BUSINESS WIRE)-- #ada2024--OrsoBio shares data on liver-targeted mitochondrial protonophore TLC-6740 at the 84th Scientific Sessions of the American Diabetes Association.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OrsoBio
Sign Up For FreeTo access detailed company insights
OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders. Our dedicated, highly skilled, and cohesive team of physicians and scientists bring decades of clinical and drug development experience, from academia and indust... Read More
